{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:48:52Z","timestamp":1792158532657,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05535-7","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:05:02Z","timestamp":1784657102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bibliometric analysis of programmed cell death and immunotherapy research in glioma"],"prefix":"10.1007","volume":"17","author":[{"given":"Muyuan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengke","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"5535_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12672-025-02376-8","volume":"16","author":"R Li","year":"2025","unstructured":"Li R, Yang Y, Gao Y, Lv J, Dai C, Zhai Y, et al. Knowledge map of programmed cell death in esophageal cancer: a bibliometric analysis. Discov Oncol. 2025;16:609.","journal-title":"Discov Oncol"},{"key":"5535_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19759","volume":"9","author":"E Huang","year":"2023","unstructured":"Huang E, Gao L, Yu R, Xu K, Wang L. A bibliometric analysis of programmed cell death in acute lung injury\/acute respiratory distress syndrome from 2000 to 2022. Heliyon. 2023;9:e19759.","journal-title":"Heliyon"},{"key":"5535_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12672-025-02610-3","volume":"16","author":"L Hong","year":"2025","unstructured":"Hong L, Zhao C, Wu T, Hu X, Li X, Li L. The role of programmed cell death in renal cancer: a bibliometric perspective (1998\u20132024). Discov Oncol. 2025;16:889.","journal-title":"Discov Oncol"},{"key":"5535_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s12672-025-02759-x","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, He Y, Zhang P, Wang C. Key developments and hotspots in programmed cell death in liver cancer pain: a bibliometric study. Discov Oncol. 2025;16:979.","journal-title":"Discov Oncol"},{"key":"5535_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12672-025-02913-5","volume":"16","author":"M Song","year":"2025","unstructured":"Song M, Teng C, Zheng X, Tan S, Guo Y. Global research trends on Chinese patent drugs inducing programmed cell death in cancer: a bibliometric analysis (1998\u20132024). Discov Oncol. 2025;16:1171.","journal-title":"Discov Oncol"},{"key":"5535_CR6","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s12672-025-04131-5","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Li L. Charting the growth of programmed cell death studies in uveal melanoma: a bibliometric evidence. Discov Oncol. 2025;16:2272.","journal-title":"Discov Oncol"},{"key":"5535_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.917155","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Song L, Jia J, Tian W, Lai R, Zhang Z, et al. Knowledge mapping of necroptosis from 2012 to 2021: a bibliometric analysis. Front Immunol. 2022;13:917155.","journal-title":"Front Immunol"},{"key":"5535_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10495-023-01889-3","volume":"29","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Li J, Liu B, Xie Z, He Y, Xue D, et al. Global trends in PANoptosis research: bibliometrics and knowledge graph analysis. Apoptosis. 2024;29:229\u201342.","journal-title":"Apoptosis"},{"key":"5535_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31819","volume":"10","author":"Z Peng","year":"2024","unstructured":"Peng Z, Xiao H, Tan Y, Zhang X. Spotlight on macrophage pyroptosis: a bibliometric and visual analysis from 2001 to 2023. Heliyon. 2024;10:e31819.","journal-title":"Heliyon"},{"key":"5535_CR10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1186\/s13018-023-04314-2","volume":"18","author":"XZ Liang","year":"2023","unstructured":"Liang X, Li N, Chai J, Li W, Luo D, Li G. Knowledge mapping of programmed cell death in osteonecrosis of femoral head: a bibliometric analysis (2000\u20132022). J Orthop Surg Res. 2023;18:864.","journal-title":"J Orthop Surg Res"},{"key":"5535_CR11","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/os.14133","volume":"16","author":"YF Rong","year":"2024","unstructured":"Rong Y, Liang X, Jiang K, Jia H, Li H, Lu B, et al. Global trends in research of programmed cell death in osteoporosis: a bibliometric and visualized analysis (2000\u20132023). Orthop Surg. 2024;16:1783\u2013800.","journal-title":"Orthop Surg"},{"key":"5535_CR12","doi-asserted-by":"publisher","first-page":"1273634","DOI":"10.3389\/fendo.2023.1273634","volume":"14","author":"HY Zhang","year":"2023","unstructured":"Zhang H, Yu H, Zhao G, Jiang X, Gao G, Wei B. Global research trends in immunotherapy for glioma: a comprehensive visualization and bibliometric analysis. Front Endocrinol (Lausanne). 2023;14:1273634.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5535_CR13","doi-asserted-by":"publisher","first-page":"1060436","DOI":"10.3389\/fnut.2022.1060436","volume":"9","author":"R Li","year":"2022","unstructured":"Li R, Huang Q, Ye C, Wu C, Luo N, Lu Y, et al. Bibliometric and visual analysis in the field of ketogenic diet on cancer from 2012 to 2021. Front Nutr. 2022;9:1060436.","journal-title":"Front Nutr"},{"key":"5535_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.969217","volume":"13","author":"K Liu","year":"2022","unstructured":"Liu K, Zhao S, Li J, Zheng Y, Wu H, Kong J, et al. Knowledge mapping and research hotspots of immunotherapy in renal cell carcinoma: a text-mining study from 2002 to 2021. Front Immunol. 2022;13:969217.","journal-title":"Front Immunol"},{"key":"5535_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1578838","volume":"16","author":"Y Huang","year":"2025","unstructured":"Huang Y, Ma X, Zhu H, Shen C, Hu K, Yu Y, et al. Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1\/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summary. Front Immunol. 2025;16:1578838.","journal-title":"Front Immunol"},{"key":"5535_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2243669","volume":"19","author":"H Zhu","year":"2003","unstructured":"Zhu H, Wang X, Lu S, Jianqiang W, Ou K, Li N. Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003-2022. Hum Vaccin Immunother. 2003;19:2243669.","journal-title":"Hum Vaccin Immunother"},{"key":"5535_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1299253","volume":"15","author":"W Fan","year":"1989","unstructured":"Fan W, Tang J, Tang S, Lin Z, Li M, Zhang Z, et al. Bibliometric analysis of photodynamic therapy and immune response from 1989\u20132023. Front Pharmacol. 1989;15:1299253.","journal-title":"Front Pharmacol"},{"key":"5535_CR18","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.3748\/wjg.v29.i40.5593","volume":"29","author":"YN Li","year":"2023","unstructured":"Li Y, Xie B, Zhang Y, He M, Xing Y, Mu D, et al. Advances and key focus areas in gastric cancer immunotherapy: a comprehensive scientometric and clinical trial review (1999\u20132023). World J Gastroenterol. 2023;29:5593\u2013617.","journal-title":"World J Gastroenterol"},{"key":"5535_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2390727","volume":"20","author":"Y Chen","year":"2024","unstructured":"Chen Y, Lu X, Peng G, Liu S, Wang M, Hou H. A bibliometric analysis of research on PD-1\/PD-L1 in urinary tract tumors. Hum Vaccin Immunother. 2024;20:2390727.","journal-title":"Hum Vaccin Immunother"},{"key":"5535_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdad009","volume":"5","author":"P Sharma","year":"2023","unstructured":"Sharma P, Aaroe A, Liang J, Puduvalli VK. Tumor microenvironment in glioblastoma: current and emerging concepts. Neuro-oncol Adv. 2023;5:vdad009.","journal-title":"Neuro-oncol Adv"},{"key":"5535_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","volume":"9","author":"A Buonfiglioli","year":"2021","unstructured":"Buonfiglioli A, Hambardzumyan D. Macrophages and microglia: the cerberus of glioblastoma. Acta Neuropathol Commun. 2021;9:54.","journal-title":"Acta Neuropathol Commun"},{"key":"5535_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/neuroglia6010013","volume":"6","author":"E Demir","year":"2025","unstructured":"Demir E, Montgomery D, Saloum A, Yaghi N, Karsy M. Current understanding regarding the glioma microenvironment and impact of the immune system. Neuroglia. 2025;6:13.","journal-title":"Neuroglia"},{"key":"5535_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-pathmechdis-042524-025950","volume":"21","author":"J Li","year":"2026","unstructured":"Li J, Ross JL, Hambardzumyan D, Brat DJ. Immunopathology of glioblastoma. Annu Rev Pathol. 2026;21:135\u201362.","journal-title":"Annu Rev Pathol"},{"key":"5535_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40364-025-00863-2","volume":"13","author":"J Cvitkovi\u0107","year":"2025","unstructured":"Cvitkovi\u0107 J, Tan W-L, Jiang T, Zhao Z. Glioma tumor microenvironment and immunotherapy: past, present, and future. Biomark Res. 2025;13:150.","journal-title":"Biomark Res"},{"key":"5535_CR25","doi-asserted-by":"publisher","first-page":"1393173","DOI":"10.3389\/fimmu.2024.1393173","volume":"15","author":"C Sun","year":"2024","unstructured":"Sun C, Wang S, Ma Z, Zhou J, Ding Z, Yuan G, et al. Neutrophils in glioma microenvironment: from immune function to immunotherapy. Front Immunol. 2024;15:1393173.","journal-title":"Front Immunol"},{"key":"5535_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-024-03222-4","volume":"21","author":"J Wen","year":"2024","unstructured":"Wen J, Liu D, Zhu H, Shu K. Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy. J Neuroinflammation. 2024;21:226.","journal-title":"J Neuroinflammation"},{"key":"5535_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11033-026-11525-3","volume":"53","author":"E Demir","year":"2026","unstructured":"Demir E, Rahmanipour E, Ghorbani M, Gupta K, Zeinali M, Karsy M. Neutrophils in glioblastoma: orchestrators of the tumor microenvironment and immune evasion. Mol Biol Rep. 2026;53:349.","journal-title":"Mol Biol Rep"},{"key":"5535_CR28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41423-025-01329-z","volume":"22","author":"JF Lin","year":"2025","unstructured":"Lin J, Wang T, Huang R, Tan Y, Chen D, Ju H. PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations. Cell Mol Immunol. 2025;22:996\u20131011.","journal-title":"Cell Mol Immunol"},{"key":"5535_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41417-024-00765-9","volume":"31","author":"J Gao","year":"2024","unstructured":"Gao J, Xiong A, Liu J, Li X, Wang J, Zhang L, et al. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer Gene Ther. 2024;31:970\u201383.","journal-title":"Cancer Gene Ther"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05535-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:02:37Z","timestamp":1792155757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05535-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5535"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05535-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This bibliometric study was based exclusively on publicly available bibliographic records and did not involve human participants, identifiable personal data, or animals; therefore, ethical approval was not required. Not applicable. This study did not involve human participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent to for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1450"}}